| |
| Issue |
Title |
| |
| Vol 5, No 2 (2025) |
A systematic review with meta-analysis and indirect comparison of the results of studies evaluating the efficacy and safety of ceftobiprole and ceftaroline in adult patients in the treatment of infections of various localizations |
Abstract
PDF (Rus)
|
|
Yu. M. Gomon, A. S. Petrichenko |
| |
| Vol 5, No 2 (2025) |
Implementation of microbiological monitoring for predicting the multidrug-resistant phenotype of respiratory isolates based on risk factor analysis in patients with community-acquired pneumonia |
Abstract
PDF (Rus)
|
|
O. P. Bobrova, S. K. Zyryanov, V. V. Chernaya, M. V. Statsenko, O. A. Parygina |
| |
| Vol 5, No 2 (2025) |
Methicillin-resistant staphylococci biofilms and the possibility of controlling them with chlorhexidine and polyhexanide: prospects for use in real clinical practice |
Abstract
PDF (Rus)
|
|
E. M. Gordina, A. D. Shakhmatova, A. R. Kasimova, S. S. Toropov, S. A. Bozhkova |
| |
| Vol 5, No 2 (2025) |
The ICEDORA study: clinical and demographic characteristics and treatment regimens of patients with HR+ HER2- locally advanced or metastatic breast cancer receiving CDK4/6 inhibitors in real clinical practice |
Abstract
PDF (Rus)
|
|
I. E. Khatkov, I. I. Andreyashkina, I. D. Trotsenko, O. N. Matveeva, V. A. Reznikov |
| |
| Vol 4, No 4 (2024) |
Assessment of quality of presentation of clinical trial results in Russia in accordance with CONSORT standards |
Abstract
PDF (Rus)
|
|
A. R. Kasimova, N. M. Guseinova |
| |
| 1 - 5 of 5 Items |
|
